Alphatec Holdings, Inc. (ATEC)
ATEC Stock Price Chart
Explore Alphatec Holdings, Inc. interactive price chart. Choose custom timeframes to analyze ATEC price movements and trends.
ATEC Company Profile
Discover essential business fundamentals and corporate details for Alphatec Holdings, Inc. (ATEC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
12 Jun 2006
Employees
867.00
Website
https://www.atecspine.comCEO
Patrick S. Miles
Description
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
ATEC Financial Timeline
Browse a chronological timeline of Alphatec Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Oct 2025
EPS estimate is -$0.05, while revenue estimate is $182.80M.
Earnings released on 31 Jul 2025
EPS came in at $0.02 surpassing the estimated -$0.06 by +133.33%, while revenue for the quarter reached $185.54M , beating expectations by +1.59%.
Earnings released on 1 May 2025
EPS came in at -$0.23 falling short of the estimated -$0.12 by -91.67%, while revenue for the quarter reached $169.18M , missing expectations by -5.41%.
Earnings released on 26 Feb 2025
EPS came in at -$0.23 falling short of the estimated -$0.19 by -21.05%, while revenue for the quarter reached $176.79M , beating expectations by +2.35%.
Earnings released on 30 Oct 2024
EPS came in at -$0.28 falling short of the estimated -$0.27 by -3.70%, while revenue for the quarter reached $150.72M , missing expectations by -11.50%.
Earnings released on 31 Jul 2024
EPS came in at -$0.29 falling short of the estimated -$0.26 by -11.54%, while revenue for the quarter reached $145.57M , missing expectations by -1.15%.
Earnings released on 7 May 2024
EPS came in at -$0.34 falling short of the estimated -$0.33 by -3.03%, while revenue for the quarter reached $138.48M , beating expectations by +3.31%.
Earnings released on 27 Feb 2024
EPS came in at -$0.37 falling short of the estimated -$0.28 by -32.14%, while revenue for the quarter reached $137.97M , beating expectations by +5.31%.
Earnings released on 6 Nov 2023
EPS came in at -$0.35 falling short of the estimated -$0.30 by -16.67%, while revenue for the quarter reached $118.26M , missing expectations by -7.74%.
Earnings released on 3 Aug 2023
EPS came in at -$0.43 falling short of the estimated -$0.30 by -43.33%, while revenue for the quarter reached $116.92M , beating expectations by +6.40%.
Earnings released on 4 May 2023
EPS came in at -$0.40 falling short of the estimated -$0.32 by -25.00%, while revenue for the quarter reached $109.11M , beating expectations by +4.21%.
Earnings released on 28 Feb 2023
EPS came in at -$0.33 falling short of the estimated -$0.30 by -10.00%, while revenue for the quarter reached $105.94M , beating expectations by +3.71%.
Earnings released on 3 Nov 2022
EPS came in at -$0.35 falling short of the estimated -$0.32 by -9.37%, while revenue for the quarter reached $89.84M , beating expectations by +8.32%.
Earnings released on 4 Aug 2022
EPS came in at -$0.36 falling short of the estimated -$0.35 by -2.86%, while revenue for the quarter reached $84.15M , beating expectations by +7.77%.
Earnings released on 5 May 2022
EPS came in at -$0.43 falling short of the estimated -$0.29 by -48.28%, while revenue for the quarter reached $70.93M , beating expectations by +7.29%.
Earnings released on 1 Mar 2022
EPS came in at -$0.40 falling short of the estimated -$0.31 by -29.03%, while revenue for the quarter reached $73.96M , beating expectations by +6.58%.
Earnings released on 4 Nov 2021
EPS came in at -$0.43 falling short of the estimated -$0.23 by -86.96%, while revenue for the quarter reached $62.88M , beating expectations by +37.67%.
Earnings released on 3 Aug 2021
EPS came in at -$0.30 falling short of the estimated -$0.20 by -50.00%, while revenue for the quarter reached $62.25M , beating expectations by +6.41%.
Earnings released on 6 May 2021
EPS came in at -$0.16 surpassing the estimated -$0.19 by +15.79%, while revenue for the quarter reached $44.12M , beating expectations by +42.86%.
Earnings released on 4 Mar 2021
EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $43.95M .
Earnings released on 5 Nov 2020
EPS came in at -$0.18 surpassing the estimated -$0.25 by +28.00%, while revenue for the quarter reached $41.16M , meeting expectations.
ATEC Stock Performance
Access detailed ATEC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.